Supply TypeManufacturer, Exporter, Supplier, Retailer, Importer, Trader, Buying House
Preferred Buyer Location All over the world
What Is Eylea? Eylea (aflibercept) is a recombinate protein indicated for the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD). AMD is a common cause of blindness. Eylea is a drug used to treat wet age-related macular degeneration (AMD). It is also used to treat diabetic eye disease and other problems of the retina. It is injected into the eye to help slow vision loss from these and certain other diseases. Eylea is the brand name for the drug, which is called aflibercept.